© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > “compound 4d”
<< Back to November
oral selective PI3K_ kinase inhibitor
<10 mg proj. human dose
from virtual screening and opt.
ACS Med. Chem. Lett., Nov. 19, 2020
Merck, Boston, CA
“compound 4d” (Merck oral selective PI3K delta kinase inhibitor)
Unlock this content with a Premium membership to read it now.